Beneficient Proposes Settlement to Erase Disputed HCLP Debt of About $130 Million
Key Facts
Beneficient proposed a consensual settlement that would cancel disputed HCLP debt, including approximately $130 million in principal and accrued interest, according to a disclosure the company filed with the U.S. Securities and Exchange Commission on September 23. The company presents the proposal as part of a broader effort to address obligations connected to Brad Heppner, its CEO and former chairman of the board, rather than as an effective cancellation of the debt. Beneficient had not reached a definitive agreement on the proposal at the time of the disclosure. It also said it could not guarantee a consensual settlement. If that does not happen, the company indicated it could pursue available claims and remedies, without announcing a new lawsuit.
Beneficient disputes the validity, enforceability, ownership, amount and value of the debt, according to its disclosure. The proposal is based on an arrangement that combines resolution of the financial claim with a reorganization of Heppner’s interests in the company and its subsidiaries. Putting forward the settlement does not mean HCLP has agreed to it or that the claim has been extinguished; the disclosure describes it as a proposal that has not yet become a binding agreement. The company says completing the settlement would eliminate most of its debt, without describing its balance sheet as debt-free or unleveraged. The potential financial impact therefore remains contingent on completion of an agreement and its final terms.
The proposal would convert Heppner’s interests, including preferred stock in a Beneficient subsidiary, into 162,132 shares of the company’s Class A common stock. The aggregate liquidation preference of the preferred shares included in the conversion is about $850 million, according to the exhibit filed with the SEC. This puts the issuance of new shares at the center of the proposed settlement, alongside the resolution of the debt. If carried out, the share issuance would change the ownership structure and affect existing shareholders’ stakes, while the disclosure does not specify the final impact on their ownership percentages. The figures and terms remain tied to a proposal that has not become a definitive agreement.
The agreement also proposes terminating or invalidating the remaining contractual arrangements with Heppner or his affiliates, and cancelling without payment amounts Beneficient says are due under those arrangements. The company estimates those amounts at about $88 million. This provision separates the disputed debt owed to HCLP, which is about $130 million, from other claims the company says are due under the arrangements. The company says the proposed settlement would end those obligations, but that depends on reaching and completing an agreement. The disclosure does not say these amounts have already been cancelled.
The proposal comes as Beneficient says no principal or interest payments on the First and Second Loan Agreements have been made since an interest payment in March 2023. This provides a timeline for the debt dispute, which includes claims related to the two loan agreements. In its disclosure for the quarter ended June 30, 2026, the company attributed this information to the agreements, without changing its current description of the debt as disputed. Any cancellation or modification of the obligation remains contingent on the outcome of negotiations or any legal route the company may choose. The disclosure gave no guarantee that the efforts would result in the settlement Beneficient is proposing.
The company’s settlement effort is linked to Heppner’s criminal case. The U.S. Department of Justice said a jury convicted him on May 7, 2026, on charges of securities fraud, wire fraud, conspiracy and making false statements to auditors. Beneficient said in its September disclosure that it was seeking to complete the settlement before his sentencing, which was then scheduled for October 21, 2026. That date was in the future when the proposal was published, and the disclosure does not establish that the settlement was completed before then. The financial dispute between the company and HCLP remains separate from the outcome of the criminal case, although Heppner’s interests are included in the proposal. The available information contains no update on the sentencing outcome or the progress of negotiations after the date set by the company.
One upcoming date announced by the company is a special shareholder meeting on October 29, 2026, at 9 a.m. Central Time, according to the definitive proxy statement filed with the U.S. Securities and Exchange Commission. The disclosure does not say the meeting will resolve the HCLP dispute or approve the proposed settlement. In trading ahead of the meeting, BENF closed at $0.7952 on October 27, according to EL7 data. No further details on the stock’s trading range in that session were included in the information provided. The meeting remains an occasion to follow shareholder matters, while Beneficient has not announced a definitive agreement on the debt.